Real-Time MoneyWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time MoneyWire is available only to registered users. This is best for professional traders and people who track markets actively.
The division bench of the Delhi High Court on Thursday issued notices to E.R. Squibb and Sons, LLC and others on Zydus Lifesciences Ltd.'s plea against a single judge's order barring the latter company from manufacturing, selling biosimilar of E.R. Squibb's patent Nivolumab. Nivolumab is a therapeutic antibody used in treatment of various forms of cancer.
Share this Story:
